PRESS RELEASE
29 January 2026

Parkland Hospital Secures Final Judgment In Closely Watched Organ Transplant Qui Tam

SM
Sheppard Mullin Richter & Hampton

Contributor

Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
Sheppard Mullin's White Collar Defense and Investigations team secured a complete win for Parkland Health and Hospital System (Parkland) in a closely watched qui tam action in the Western District of Texas.
United States

Sheppard Mullin's White Collar Defense and Investigations team secured a complete win for Parkland Health and Hospital System (Parkland) in a closely watched qui tam action in the Western District of Texas. The relator asserted federal False Claims Act and analogous state law claims alleging a broad fraud scheme involving participants in the national organ transplant system. The relator specifically alleged that Parkland, working with UT Southwestern Medical Center, engaged in practices that harmed Parkland transplant patients and inflated reimbursement claims submitted to Medicare and other government payors. These allegations drew significant public attention, including national media coverage such as a Washington Post report.

The Court granted Parkland's Rule 12(b)(6) motion and dismissed all claims against Parkland in a January 16 memorandum opinion and order, holding that the complaint did not plead a sufficiently specific fraud theory as to Parkland under the heightened standards applicable to FCA claims. The Court also dismissed the relator's retaliation claim and, after disposing of the federal theories, declined to exercise supplemental jurisdiction over the remaining state-law claims.

Following those dismissals, the relator moved for leave to file a third amended complaint in an attempt to revive claims. On January 26, the Court denied leave to amend and entered final judgment, dismissing the action with prejudice and closing the case. The Court held that relator had already been afforded ample opportunity to plead his best case and concluded that the deficiencies and gaps identified in the dismissal orders were incurable, rendering any further amendment futile.

This result not only vindicates Parkland, a staple in the Dallas community, but also brings an end to contentious litigation that drew significant attention due to its implications for national organ transplant practices and government healthcare programs. The rulings reinforce the importance of rigorous pleading standards for FCA claims and represent a significant win for the Parkland team.

The team was led by Bill Mateja, Elisha Kobre, Margia Corner, Jason Hoggan, Lauryn Vigil and Rebecca James.

The case is United States ex rel. Chase v. Parkland Health & Hosp. Sys., Western District of Texas, Case No. 5:23-cv-00381.

Contributor

Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More